https://www.msbase.org/ 2026-02-19 1.0 always https://www.msbase.org/about-us/ 2025-07-21 https://www.msbase.org/about-us/msbase-foundation/ 2025-07-02 https://www.msbase.org/about-us/board-of-directors-slg/ 2025-11-30 https://www.msbase.org/about-us/foundation-registry-staff/ 2025-12-05 https://www.msbase.org/about-us/partnerships/ 2025-07-21 https://www.msbase.org/about-us/strategy-on-a-page/ 2025-07-01 https://www.msbase.org/membership/ 2025-07-21 https://www.msbase.org/membership/benefits-of-membership/ 2025-12-15 https://www.msbase.org/membership/documents-resources/ 2026-02-17 https://www.msbase.org/membership/member-testimonials/ 2025-12-15 https://www.msbase.org/membership/fellowships/ 2026-02-02 https://www.msbase.org/membership/fellowships/fellowship-form/ 2026-02-08 https://www.msbase.org/data-findings/ 2025-07-01 https://www.msbase.org/data-findings/how-is-data-collected/ 2025-07-01 https://www.msbase.org/data-findings/security-governance/ 2025-07-21 https://www.msbase.org/data-findings/patient-enrolment/ 2025-07-01 https://www.msbase.org/data-findings/patient-demographics/ 2025-07-01 https://www.msbase.org/data-findings/ms-severity-rank-calculator/ 2025-07-01 https://www.msbase.org/research/ 2025-07-01 https://www.msbase.org/research/sub-studies/ 2025-07-01 https://www.msbase.org/research/peer-reviewed-journal-articles/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/ 2025-07-14 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/neurol/ 2025-06-30 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/jmsni/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/neurotherapeutics/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/comput-methods-programs-biomed/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/cns-drugs/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/jnnp/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/therapeutic-advances-in-neurological-disorders/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/neurol-neuroimmunol-neuroinflamm/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/mult-scler/ 2025-07-03 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/plos-digit-health/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/lancet-child-adolesc-health/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/front-neurol/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/j-med-econ/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/jama-neurol/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/brain/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/neurodegener-dis-manag/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/eur-j-neurol/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/mult-scler-relat-disord/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/clin-epigenetics/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/bmc-med-res-methodol/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/clin-drug-investig/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/j-neurol-sci/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/neuroimage-clin/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/j-neurol/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/lancet-neurol/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/j-clin-neurosci/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/ann-clin-transl-neurol/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/pharmacoeconomics/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/jama/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/ann-neurol/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/neurol-clin-pract/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/mult-scler-j-exp-transl-clin/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/plos-one/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/acta-neurol-scand/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/jama-netw-open/ 2025-09-19 https://www.msbase.org/research/peer-reviewed-journal-articles/themes/curr-neuropharmacol/ 2026-04-02 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/ 2025-03-24 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/first-year-treatment-response-predicts-the-following-5-year-disease-course-in-patients-with-relapsing-remitting-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/explainable-time-to-progression-predictions-in-multiple-sclerosis/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/treatment-de-escalation-in-relapsing-remitting-multiple-sclerosis-an-observational-study/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disease-modifying-treatment-and-disability-progression-in-subclasses-of-patients-with-primary-progressive-ms-results-from-the-big-ms-data-network/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/prevalence-of-progression-independent-of-relapse-activity-and-relapse-associated-worsening-in-patients-with-aqp4-igg-positive-nmosd/ 2025-07-18 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-impact-of-covid-19-infection-on-multiple-sclerosis-disease-course-across-12-countries-a-propensity-score-matched-cohort-study/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disease-activity-in-pregnant-and-postpartum-women-with-multiple-sclerosis-receiving-ocrelizumab-or-other-disease-modifying-therapies/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/effectiveness-of-disease-modifying-treatment-on-spinal-cord-lesion-formation-in-relapse-onset-multiple-sclerosis-an-msbase-registry-study/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/predictors-of-relapse-risk-and-treatment-response-in-aqp4-igg-positive-and-seronegative-nmosd-a-multicentre-study/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/effectiveness-of-cladribine-compared-to-fingolimod-natalizumab-ocrelizumab-and-alemtuzumab-in-relapsing-remitting-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/machine-learning-based-prediction-of-disability-progression-in-multiple-sclerosis-an-observational-international-multi-center-study/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/a-multi-centre-longitudinal-study-analysing-multiple-sclerosis-disease-modifying-therapy-prescribing-patterns-during-the-covid-19-pandemic/ 2025-07-18 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-of-dimethyl-fumarate-versus-non-specific-immunosuppressants-real-world-evidence-from-msbase/ 2025-07-18 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/leukocyte-telomere-length-in-multiple-sclerosis-relationship-between-disability-severity-and-pregnancy-history/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/routine-csf-parameters-as-predictors-of-disease-course-in-multiple-sclerosis-an-msbase-cohort-study/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disease-modifying-therapies-in-managing-disability-worsening-in-paediatric-onset-multiple-sclerosis-a-longitudinal-analysis-of-global-and-national-registries/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/big-multiple-sclerosis-data-network-an-international-registry-research-network/ 2025-08-12 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/effectiveness-of-autologous-haematopoietic-stem-cell-transplantation-versus-natalizumab-in-progressive-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disease-modifying-therapies-in-managing-disability-worsening-in-paediatric-onset-multiple-sclerosis-a-longitudinal-analysis-of-global-and-national-registries-1/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-of-natalizumab-fingolimod-and-injectable-therapies-in-pediatric-onset-multiple-sclerosis-a-registry-based-study/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/no-evidence-for-association-between-rs10191329-severity-locus-and-longitudinal-disease-severity-in-1813-relapse-onset-multiple-sclerosis-patients-from-the-msbase-registry/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparing-ocrelizumab-to-interferonglatiramer-acetate-in-people-with-multiple-sclerosis-over-age-60/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/long-term-clinical-outcomes-in-patients-with-multiple-sclerosis-who-are-initiating-disease-modifying-therapy-with-natalizumab-compared-with-bracetd-first-line-therapies/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/emulating-randomised-clinical-trials-in-relapsing-remitting-multiple-sclerosis-with-non-randomised-real-world-evidence-an-application-using-data-from-the-msbase-registry/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/predictors-of-treatment-switching-in-the-big-multiple-sclerosis-data-network/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-and-cost-effectiveness-of-natalizumab-and-fingolimod-in-rapidly-evolving-severe-relapsing-remitting-multiple-sclerosis-in-the-united-kingdom/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/examining-the-environmental-risk-factors-of-progressive-onset-and-relapsing-onset-multiple-sclerosis-recruitment-challenges-potential-bias-and-statistical-strategies/ 2025-07-18 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-of-autologous-hematopoietic-stem-cell-transplant-vs-fingolimod-natalizumab-and-ocrelizumab-in-highly-active-relapsing-remitting-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/effectiveness-of-multiple-disease-modifying-therapies-in-relapsing-remitting-multiple-sclerosis-causal-inference-to-emulate-a-multiarm-randomised-trial/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/risk-of-secondary-progressive-multiple-sclerosis-after-early-worsening-of-disability/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-risk-of-secondary-progressive-multiple-sclerosis-is-geographically-determined-but-modifiable/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/early-non-disabling-relapses-are-important-predictors-of-disability-accumulation-in-people-with-relapsing-remitting-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/rituximab-vs-ocrelizumab-in-relapsing-remitting-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/a-plain-language-summary-on-the-effectiveness-of-cladribine-tablets-compared-with-other-oral-treatments-for-multiple-sclerosis-results-from-the-msbase-registry/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparison-between-dimethyl-fumarate-fingolimod-and-ocrelizumab-after-natalizumab-cessation/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disability-accrual-in-primary-and-secondary-progressive-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-in-multiple-sclerosis-a-methodological-comparison/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/external-validation-of-a-clinical-prediction-model-in-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/variability-of-the-response-to-immunotherapy-among-subgroups-of-patients-with-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/heterogeneity-on-long-term-disability-trajectories-in-patients-with-secondary-progressive-ms-a-latent-class-analysis-from-big-ms-data-network/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/switching-to-natalizumab-or-fingolimod-in-multiple-sclerosis-comparative-effectiveness-and-effect-of-pre-switch-disease-activity/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/whole-blood-methylation-signatures-are-associated-with-and-accurately-classify-multiple-sclerosis-disease-severity/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/external-validation-of-a-clinical-prediction-model-in-multiple-sclerosis-1/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/not-all-roads-lead-to-the-immune-system-the-genetic-basis-of-multiple-sclerosis-severity/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-of-cladribine-tablets-versus-other-oral-disease-modifying-treatments-for-multiple-sclerosis-results-from-msbase-registry/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/updated-results-of-the-covid-19-in-ms-global-data-sharing-initiative-anti-cd20-and-other-risk-factors-associated-with-covid-19-severity/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparing-switch-to-ocrelizumab-cladribine-or-natalizumab-after-fingolimod-treatment-cessation-in-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/early-predictors-of-disability-in-paediatric-multiple-sclerosis-evidence-from-a-multi-national-registry/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/heterogeneity-on-long-term-disability-trajectories-in-patients-with-secondary-progressive-ms-a-latent-class-analysis-from-big-ms-data-network-1/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disease-reactivation-after-cessation-of-disease-modifying-therapy-in-patients-with-relapsing-remitting-multiple-sclerosis/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/prediction-of-multiple-sclerosis-outcomes-when-switching-to-ocrelizumab/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/impact-of-methodological-choices-in-comparative-effectiveness-studies-application-in-natalizumab-versus-fingolimod-comparison-among-patients-with-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/confirmed-disability-progression-as-a-marker-of-permanent-disability-in-multiple-sclerosis/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/association-of-latitude-and-exposure-to-ultraviolet-b-radiation-with-severity-of-multiple-sclerosis-an-international-registry-study/ 2025-07-18 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/multiple-sclerosis-severity-score-msss-improves-the-accuracy-of-individualized-prediction-in-ms/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/multiple-sclerosis-relapses-following-cessation-of-fingolimod/ 2025-07-23 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-and-cost-effectiveness-of-natalizumab-and-fingolimod-in-patients-with-inadequate-response-to-disease-modifying-therapies-in-relapsing-remitting-multiple-sclerosis-in-the-united-kingdom/ 2025-07-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/long-term-outcomes-in-patients-presenting-with-optic-neuritis-analyses-of-the-msbase-registry/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/natalizumab-versus-fingolimod-in-patients-with-relapsing-remitting-multiple-sclerosis-a-subgroup-analysis-from-three-international-cohorts/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/brain-atrophy-and-lesion-burden-are-associated-with-disability-progression-in-a-multiple-sclerosis-real-world-dataset-using-only-t2-flair-the-neurostream-msbase-study/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/effects-of-high-and-low-efficacy-therapy-in-secondary-progressive-multiple-sclerosis/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/utilization-of-multiple-sclerosis-therapies-in-the-middle-east-over-a-decade-2009-2018/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/corrigendum-to-longitudinal-machine-learning-modeling-of-ms-patient-trajectories-improves-predictions-of-disability-progression-computer-methods-and-programs-in-biomedicine-volume-208-september-2021-106180/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-effectiveness-of-natalizumab-vs-fingolimod-a-comparison-of-international-registry-studies/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-msbase-pregnancy-neonatal-outcomes-and-women-s-health-registry/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/natalizumab-fingolimod-and-dimethyl-fumarate-use-and-pregnancy-related-relapse-and-disability-in-women-with-multiple-sclerosis/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/risk-of-requiring-a-wheelchair-in-primary-progressive-multiple-sclerosis-data-from-the-oratorio-trial-and-the-msbase-registry/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/determinants-of-therapeutic-lag-in-multiple-sclerosis/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/effect-of-disease-modifying-therapy-on-disability-in-relapsing-remitting-multiple-sclerosis-over-15-years/ 2025-07-29 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/treatment-response-score-to-glatiramer-acetate-or-interferon-beta-1a/ 2025-08-06 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/delay-from-treatment-start-to-full-effect-of-immunotherapies-for-multiple-sclerosis/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/association-of-pregnancy-with-the-onset-of-clinically-isolated-syndrome/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/association-of-sustained-immunotherapy-with-disability-outcomes-in-patients-with-active-secondary-progressive-multiple-sclerosis/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/prediction-of-on-treatment-disability-worsening-in-rrms-with-the-magnims-score/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disability-outcomes-of-early-cerebellar-and-brainstem-symptoms-in-multiple-sclerosis/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/real-world-effectiveness-of-cladribine-for-australian-patients-with-multiple-sclerosis-an-msbase-registry-substudy/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/early-clinical-markers-of-aggressive-multiple-sclerosis/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/timing-of-high-efficacy-therapy-for-multiple-sclerosis-a-retrospective-observation-cohort-study/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/clinical-and-therapeutic-predictors-of-disease-outcomes-in-aqp4-iggplus-neuromyelitis-optica-spectrum-disorder/ 2025-08-07 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/haematopoietic-stem-cell-transplant-versus-immune-reconstitution-therapy-in-relapsing-multiple-sclerosis/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/corticosteroid-treatment-of-multiple-sclerosis-relapses-is-associated-with-lower-disability-worsening-over-5-years/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/four-years-on-pregnancy-and-birth-outcomes-reported-in-the-msbase-pregnancy-neonatal-outcomes-and-womens-health-registry-2020-2024/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/standardized-definition-of-progression-independent-of-relapse-activity-pira-in-relapsing-remitting-multiple-sclerosis/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/progression-independent-of-relapse-activity-and-relapse-associated-worsening-in-seronegative-nmosd-an-international-cohort-study/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/predicting-5-year-edss-in-multiple-sclerosis-with-lstm-networks-a-deep-learning-approach-to-disease-progression/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/longitudinal-trajectories-of-digital-cognitive-biomarkers-for-multiple-sclerosis/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/estimation-of-transition-probabilities-from-a-large-cohort-6000-of-australians-living-with-multiple-sclerosis-ms-for-changing-disability-severity-classifications-ms-phenotype-and-disease-modifying-therapy-classifications/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/longitudinal-trajectories-of-digital-upper-limb-biomarkers-for-multiple-sclerosis/ 2025-08-14 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/risk-of-secondary-progressive-multiple-sclerosis-a-longitudinal-study/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-msbase-registry-informing-clinical-practice/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparison-of-fingolimod-dimethyl-fumarate-and-teriflunomide-for-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/incidence-of-pregnancy-and-disease-modifying-therapy-exposure-trends-in-women-with-multiple-sclerosis-a-contemporary-cohort-study/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/anti-inflammatory-disease-modifying-treatment-and-disability-progression-in-primary-progressive-multiple-sclerosis-a-cohort-study/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/association-of-initial-disease-modifying-therapy-with-later-conversion-to-secondary-progressive-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/association-of-inflammation-and-disability-accrual-in-patients-with-progressive-onset-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/silent-lesions-on-mri-imaging-shifting-goal-posts-for-treatment-decisions-in-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/cladribine-versus-fingolimod-natalizumab-and-interferon-β-for-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/predictors-of-relapse-and-disability-progression-in-ms-patients-who-discontinue-disease-modifying-therapy/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/long-term-disability-trajectories-in-primary-progressive-ms-patients-a-latent-class-growth-analysis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/lymphocyte-count-in-peripheral-blood-is-not-associated-with-the-level-of-clinical-response-to-treatment-with-fingolimod/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/towards-personalized-therapy-for-multiple-sclerosis-prediction-of-individual-treatment-response/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/anti-inflammatory-disease-modifying-treatment-and-short-term-disability-progression-in-spms/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/quantifying-risk-of-early-relapse-in-patients-with-demyelinating-events-prediction-in-clinical-practice/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/incidence-and-prevalence-of-nmosd-in-australia-and-new-zealand/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/prognostic-indicators-in-pediatric-clinically-isolated-syndrome/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/treatment-effectiveness-of-alemtuzumab-compared-with-natalizumab-fingolimod-and-interferon-beta-in-relapsing-remitting-multiple-sclerosis-a-cohort-study/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/data-quality-evaluation-for-observational-multiple-sclerosis-registries/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/highly-active-immunomodulatory-therapy-ameliorates-accumulation-of-disability-in-moderately-advanced-and-advanced-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/contribution-of-different-relapse-phenotypes-to-disability-in-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/higher-latitude-is-significantly-associated-with-an-earlier-age-of-disease-onset-in-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/discontinuing-disease-modifying-therapy-in-ms-after-a-prolonged-relapse-free-period-a-propensity-score-matched-study/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/defining-secondary-progressive-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/predictors-of-long-term-disability-accrual-in-relapse-onset-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-efficacy-of-first-line-natalizumab-vs-ifn-β-or-glatiramer-acetate-in-relapsing-ms/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/risk-of-early-relapse-following-the-switch-from-injectables-to-oral-agents-for-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-effect-of-oral-immunomodulatory-therapy-on-treatment-uptake-and-persistence-in-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/defining-reliable-disability-outcomes-in-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-effectiveness-of-glatiramer-acetate-and-interferon-beta-formulations-in-relapsing-remitting-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/multiple-sclerosis-in-latin-america-a-different-disease-course-severity-a-collaborative-study-from-the-msbase-registry/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/male-sex-is-independently-associated-with-faster-disability-accumulation-in-relapse-onset-ms-but-not-in-primary-progressive-ms/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/bremso-a-simple-score-to-predict-early-the-natural-course-of-multiple-sclerosis/ 2025-09-09 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/predictors-of-disability-worsening-in-clinically-isolated-syndrome/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparative-efficacy-of-switching-to-natalizumab-in-active-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/comparison-of-switch-to-fingolimod-or-interferon-betaglatiramer-acetate-in-active-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/switch-to-natalizumab-versus-fingolimod-in-active-relapsing-remitting-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/seasonal-variation-of-relapse-rate-in-multiple-sclerosis-is-latitude-dependent/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/risk-of-relapse-phenotype-recurrence-in-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/predictors-and-dynamics-of-postpartum-relapses-in-women-with-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/fingolimod-after-natalizumab-and-the-risk-of-short-term-relapse/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/sex-as-a-determinant-of-relapse-incidence-and-progressive-course-of-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/persistence-on-therapy-and-propensity-matched-outcome-comparison-of-two-subcutaneous-interferon-beta-1a-dosages-for-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/historical-changes-of-seasonal-differences-in-the-frequency-of-multiple-sclerosis-clinical-attacks-a-multicenter-study/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/fluctuations-of-ms-births-and-uv-light-exposure/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-australian-multiple-sclerosis-ms-immunotherapy-study-a-prospective-multicentre-study-of-drug-utilisation-using-the-msbase-platform/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/geographical-variations-in-sex-ratio-trends-over-time-in-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/increasing-age-at-disability-milestones-among-ms-patients-in-the-msbase-registry/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-frequency-of-csf-oligoclonal-banding-in-multiple-sclerosis-increases-with-latitude/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/country-sex-edss-change-and-therapy-choice-independently-predict-treatment-discontinuation-in-multiple-sclerosis-and-clinically-isolated-syndrome/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-kurtzke-edss-rank-stability-increases-4-years-after-the-onset-of-multiple-sclerosis-results-from-the-msbase-registry/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/msbase-an-international-online-registry-and-platform-for-collaborative-outcomes-research-in-multiple-sclerosis/ 2025-09-10 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/pregnancy-related-disease-outcomes-in-women-with-moderate-to-severe-multiple-sclerosis-disability/ 2025-09-19 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/disease-course-after-pregnancy-in-women-with-progressive-multiple-sclerosis-symptoms/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/the-impact-of-national-policies-on-reimbursement-of-disease-modifying-therapies-for-multiple-sclerosis-on-disease-outcomes-slovenia-versus-croatia/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/menopause-impact-on-multiple-sclerosis-disability-progression/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/moderate-high-efficacy-disease-modifying-therapies-reduce-relapse-risk-in-late-onset-multiple-sclerosis/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/big-multiple-sclerosis-data-network-novel-modelling-approaches-for-real-world-data-analysis/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/managing-reactivation-of-multiple-sclerosis-during-treatment-with-natalizumab/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/real-world-effectiveness-of-ocrelizumab-in-relapsing-multiple-sclerosis-an-msbase-registry-sub-study/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/real-world-effectiveness-of-horizontal-switching-between-disease-modifying-therapies-in-multiple-sclerosis-a-retrospective-analysis-of-the-msbase-registry/ 2026-01-21 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/impact-of-age-at-onset-on-relapse-and-disability-in-aqp4-igg-neuromyelitis-optica-spectrum-disorder/ 2026-04-02 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/ocrelizumab-discontinuation-vs-continuation-after-safety-events-comparative-insights-from-msbase/ 2026-04-02 https://www.msbase.org/research/peer-reviewed-journal-articles/articles/1comparative-effectiveness-of-anti-cd20-therapies-and-s1p-receptor-modulators-in-late-onset-multiple-sclerosis-real-world-evidence-from-the-msbase-registry/ 2026-04-02 https://www.msbase.org/news/ 2025-07-22 https://www.msbase.org/news/rss/ 2025-07-21 https://www.msbase.org/news/impact-of-age-at-onset-on-relapse-and-disability-in-aqp4-igg-neuromyelitis-optica-spectrum-disorder/ 2026-04-02 https://www.msbase.org/news/managing-reactivation-of-multiple-sclerosis-during-treatment-with-natalizumab/ 2026-03-18 https://www.msbase.org/news/real-world-effectiveness-of-horizontal-switching-between-disease-modifying-therapies-in-multiple-sclerosis-a-retrospective-analysis-of-the-msbase-registry/ 2026-03-10 https://www.msbase.org/news/moderate-high-efficacy-disease-modifying-therapies-reduce-relapse-risk-in-late-onset-multiple-sclerosis/ 2026-03-10 https://www.msbase.org/news/disease-modifying-treatment-and-disability-progression-in-subclasses-of-patients-with-primary-progressive-ms-results-from-the-big-ms-data-network/ 2025-07-02 https://www.msbase.org/news/standardized-definition-of-progression-independent-of-relapse-activity-pira-in-relapsing-remitting-multiple-sclerosis/ 2025-07-02 https://www.msbase.org/news/utility-of-icobrain-for-brain-volumetry-in-multiple-sclerosis-clinical-practice/ 2025-07-01 https://www.msbase.org/news/prevalence-of-progression-independent-of-relapse-activity-and-relapse-associated-worsening-in-patients-with-aqp4-igg-positive-nmosd/ 2025-07-01 https://www.msbase.org/news/disease-activity-in-pregnant-and-postpartum-women-with-multiple-sclerosis-receiving-ocrelizumab-or-other-disease-modifying-therapies/ 2025-07-01 https://www.msbase.org/faq/ 2025-07-21 https://www.msbase.org/contact-us/ 2025-09-16 https://www.msbase.org/sitemap/ 2025-07-21 https://www.msbase.org/privacy-policy/ 2025-07-21 https://www.msbase.org/cookie-policy/ 2025-07-23 https://www.msbase.org/azure-regions/ 2026-01-21